Skip to main content
OpenTrials
Completed

NCT Number: NCT04594096

Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer

This study will test the acceptability and feasibility of a telehealth intervention to improve communication between patients and medical providers in adolescent and young adult (AYA) cancer patients receiving chemotherapy treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

12 year–29 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Comprehensive Cancer Center

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with cancer undergoing active treatment and who have received at least two cycles of chemotherapy
  • Access to Epic MyChart (we will facilitate access to MyChart for interested patients who are not yet signed up)
  • Access to a smartphone or tablet to access EPIC MyChart telehealth appointments

Exclusion criteria

  • Non-English or non-Spanish speaking patients
  • Potentially completing therapy during study period (including follow-up period) or plans to leave UCDCCC during study period

Treatment and study plan

telehealth visits

Behavioral

Receiving telehealth visits with a medical provider (MD or NP) 2-3 days after last chemotherapy administration in the cycle

Standard of Care

Behavioral

Receiving care as usual from the UC Davis Comprehensive Cancer Center

Primary outcomes

  1. Proportion of Patients Completing the Trial

    Time frame: end of the study period (6 cycles of chemotherapy for each participant, where each cycle is 14-28 days)

    >65% of enrolled patients will complete the trial

Secondary outcomes

  1. Survey Response Rate

    Time frame: end of the study period (6 cycles of chemotherapy for each participant, where each cycle is 14-28 days)

    >%70% of enrolled patients will complete the survey instruments

  2. Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ)

    Time frame: end of the study period (6 cycles of chemotherapy for each participant, where each cycle is 14-28 days)

    A composite score of ≥40 (based on 10 items with a Likert scale of 1-5 strongly disagree to strongly agree)

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

Improving Treatment-Related Symptom Management in Adolescents and Young Adults

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Oct 20, 2020
Registry last updated
May 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.